List VENLAFAXINE HYD…
New Version
CCD No. :
CCD00404641
Product Name : VENLAFAXINE HYDROCHLORIDE
CAS No. : 99300-78-4 ;93413-69-5
MDL Number. : MFCD03658865
Formula : C17 H27 N O2 . Cl H
MolWeight : 313.866
Synonyms :
VEXOR; EFFEXOR; (+/-)-1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXANOL HYDROCHLORIDE; D,L-VENLAFAXINE, HYDROCHLORIDE; VENLIFT; VENLAFAXINE; (RS)-1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXANOL HYDROCHLORIDE; (+/-)-1-(ALPHA-((DIMETHYLAMINO)METHYL)-P-METHOXYBENZYL)CYCLOHEXANOL HYDROCHLORIDE; EFFEXOR HYDROCHLORIDE; VENLAFAXIN HCL; (+/-)-VENLAFAXINE HYDROCHLORIDE; VENLAFAXINE HYDROCHLORIDE; CYCLOHEXANOL, 1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]-, HYDROCHLORIDE (1:1); VENLAFAXINE HCL; VENALAFAXINE HCL; VENLAFAXINE HYDORCHLORIDE; 1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXANOL HYDROCHLORIDE;
Mol : VENLAFAXINE HYDRO… .mol
Product Name : VENLAFAXINE HYDROCHLORIDE
CAS No. : 99300-78-4 ;93413-69-5
MDL Number. : MFCD03658865
Formula : C17 H27 N O2 . Cl H
MolWeight : 313.866
Synonyms :
VEXOR; EFFEXOR; (+/-)-1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXANOL HYDROCHLORIDE; D,L-VENLAFAXINE, HYDROCHLORIDE; VENLIFT; VENLAFAXINE; (RS)-1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXANOL HYDROCHLORIDE; (+/-)-1-(ALPHA-((DIMETHYLAMINO)METHYL)-P-METHOXYBENZYL)CYCLOHEXANOL HYDROCHLORIDE; EFFEXOR HYDROCHLORIDE; VENLAFAXIN HCL; (+/-)-VENLAFAXINE HYDROCHLORIDE; VENLAFAXINE HYDROCHLORIDE; CYCLOHEXANOL, 1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]-, HYDROCHLORIDE (1:1); VENLAFAXINE HCL; VENALAFAXINE HCL; VENLAFAXINE HYDORCHLORIDE; 1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXANOL HYDROCHLORIDE;
Mol : VENLAFAXINE HYDRO… .mol
* If the product has intellectual property rights, a license granted is must or contact us.
- Detailed
- Suppliers(72)
- Buyers(0)
- Spectrum(0)
- MSDS(0)
- Price(28)
|
|
| Product Name： | VENLAFAXINE HYDROCHLORIDE |
| CAS： | 99300-78-4 ;93413-69-5 |
| English Synonyms： | VEXOR ; EFFEXOR ; (+/-)-1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXANOL HYDROCHLORIDE ; D,L-VENLAFAXINE, HYDROCHLORIDE ; VENLIFT ; VENLAFAXINE ; (RS)-1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXANOL HYDROCHLORIDE ; (+/-)-1-(ALPHA-((DIMETHYLAMINO)METHYL)-P-METHOXYBENZYL)CYCLOHEXANOL HYDROCHLORIDE ; EFFEXOR HYDROCHLORIDE ; VENLAFAXIN HCL ; (+/-)-VENLAFAXINE HYDROCHLORIDE ; VENLAFAXINE HYDROCHLORIDE ; CYCLOHEXANOL, 1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]-, HYDROCHLORIDE (1:1) ; VENLAFAXINE HCL ; VENALAFAXINE HCL ; VENLAFAXINE HYDORCHLORIDE ; 1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXANOL HYDROCHLORIDE |
| MDL Number.： | MFCD03658865 |
| H bond acceptor： | 3 |
| H bond donor： | 1 |
| Smile： | CN(C)CC(c1ccc(cc1)OC)C2(CCCCC2)O.Cl |
| InChi： | InChI=1S/C17H27NO2.ClH/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14;/h7-10,16,19H,4-6,11-13H2,1-3H3;1H |
| InChiKey： | InChIKey=QYRYFNHXARDNFZ-UHFFFAOYSA-N |
|
|
| Comments： | BIOCHEM/PHYSIOL ACTIONS: VENLAFAXINE IS AN ANTIDEPRESSANT. THE MECHANISM OF THE ANTIDEPRESANT ACTION OF VENLAFAXINE IN HUMANS IS ASSOCIATED WITH ITS POTENTIATION OF NEUROTRANSMITTER ACTIVITY IN THE CNS. VENLAFAXINE IS A POTENT INHIBITOR OF NEURONAL SEROTONIN AND NOREPINEPHRINE REUPTAKE AND WEAK INHIBITOR OF DOPAMINE REUPTAKE. VENLAFAXINE HAS NO SIGNIFICANT ACTIVITY FOR MUSCARINIC, HISTAMINERGIC, OR ALPHA-1 ADRENERGIC RECEPTORS IN VITRO. VENLAFAXINE DOES NOT POSSESS MAO INHIBITOR ACTIVITY GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA OTHER NOTES: SALES RESTRICTIONS MAY APPLY |
|
|
| Symbol： |
GHS07
|
| Signal word： | Warning |
| Hazard statements： | H319 |
| Precautionary statements： | P305 + P351 + P338 |
| hazard symbol： | Xi |
| Risk Code： | R:36 |
| Safe Code： | S:26 |
| WGK Germany： | 3 |
Basic Information
* If the product has intellectual property rights, a license granted is must or contact us.